Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Definitive Healthcare (DH) Other Operating Expenses (2020 - 2025)

Definitive Healthcare (DH) has disclosed Other Operating Expenses for 6 consecutive years, with $48.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Operating Expenses fell 61.51% year-over-year to $48.8 million, compared with a TTM value of $313.5 million through Dec 2025, down 61.31%, and an annual FY2025 reading of $313.5 million, down 61.31% over the prior year.
  • Other Operating Expenses was $48.8 million for Q4 2025 at Definitive Healthcare, up from $29.5 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $394.6 million in Q2 2024 and bottomed at -$248.9 million in Q3 2023.
  • Average Other Operating Expenses over 5 years is $37.1 million, with a median of -$10.0 million recorded in 2021.
  • The sharpest move saw Other Operating Expenses crashed 1642.42% in 2023, then soared 3075.61% in 2024.
  • Year by year, Other Operating Expenses stood at -$14.4 million in 2021, then surged by 169.43% to $10.0 million in 2022, then tumbled by 233.89% to -$13.4 million in 2023, then skyrocketed by 1049.48% to $126.9 million in 2024, then plummeted by 61.51% to $48.8 million in 2025.
  • Business Quant data shows Other Operating Expenses for DH at $48.8 million in Q4 2025, $29.5 million in Q3 2025, and $29.5 million in Q2 2025.